Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

Algert Global LLC trimmed its holdings in shares of Embecta Corp. (NASDAQ:EMBC – Free Report) by 31.8% in the third quarter, ...

Fintel reports that on November 27, 2024, BTIG upgraded their outlook for Embecta (NasdaqGS:EMBC) from Neutral to Buy. Analyst Price Forecast Suggests 20.45% Downside As of November 21, 2024, the ...

Embecta Corporation (EMBC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 ...

Q4 2024 Earnings Call Transcript November 26, 2024 Embecta Corp. misses on earnings expectations. Reported EPS is $ EPS, ...

Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...

Embecta Corporation ( (EMBC) ) has released its Q4 earnings. Here is a breakdown of the information Embecta Corporation presented to its ...

Debt Pay Down (Q4 2024): Additional $25 million of Term Loan B debt paid down. Embecta Corp (NASDAQ:EMBC) strengthened its core business by securing exclusive and dual-preferred contracts with key ...

Q4 2024 Earnings Conference Call November 26, 2024 8:00 AM ETCompany ParticipantsPravesh Khandelwal - VP of IRDev Kurdikar ...

Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...